TCG Labs-Soleil
Aetna Wun Trombley is an accomplished leader in the biopharmaceutical industry with extensive experience in strategic roles. Currently serving as a Strategic Board member at TCG Labs-Soleil and Chief Executive Officer at Lycia Therapeutics, Aetna has also held positions such as Board Director at Carmot Therapeutics, Inc. and President and Chief Operating Officer at NGM Biopharmaceuticals, where a focus on developing transformative therapeutics for unmet medical needs was emphasized. Aetna's earlier career included significant roles at Novartis, XenoPort, and McKinsey & Company, showcasing a strong foundation in business development and strategic management. Aetna holds a PhD in Chemistry from the Massachusetts Institute of Technology and a B.S. in Chemistry from UC San Diego.
This person is not in the org chart
This person is not in any teams
TCG Labs-Soleil
At TCG Labs-Soleil, we are establishing a pioneering venture-biotech model in collaboration with The Column Group. Our mission is to efficiently translate scientific insights into therapeutic solutions for patients facing serious diseases. Our approach integrates a dedicated venture fund (TCG Labs) with an evergreen R&D hub led by top-tier scientists (Soleil). This creates a powerful ecosystem forming and overseeing independent portfolio companies, each dedicated to single-asset biologic programs, guiding them from ideation to clinical proof of concept and positioning them for strategic partnerships and transformative medical advancements.